Concepedia
Statistics
Publications
85
Citations
10.9K
H-Index
41
Active since
1973
Affiliations
Eli Lilly (United States)(Current)
Dalhousie University
University of Michigan
Harvard University
Milken Institute
Meng H. Tan is an author at Eli Lilly (United States) specializing in medicine, diabetes mellitus, and endocrinology.
Publications per year
1973–2024
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +15
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study
Philippe Ryvlin, Lina Nashef, Samden D. Lhatoo et al. · The Lancet Neurology · 2013 · 1.1K citations
Medicine, Neurology, Epilepsy +6
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text
Medicine, Endocrinology, Pharmacology +14
Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease
Erland Erdmann, B Charbonnel, Allan M. Skene et al. · Diabetes Care · 2007 · 288 citations · Full text
Medicine, Cardiology, Pharmacotherapy +17
Increased Lipoprotein-Remnant Formation in Chronic Renal Failure
Paul J. Nestel, Noel Fidge, Meng H. Tan · New England Journal of Medicine · 1982 · 240 citations
Medicine, Biochemistry, Nephrology +17
1–5 of 85